A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...

The Alcohol and Tobacco Tax and Trade Bureau (TTB) has published a pair of proposed rules that if finalized could ...

The Senate has unanimously passed a measure that would implement labeling requirements for specific foods containing vaccines ...

China’s dominance of the market for "active pharmaceutical ingredients" — critical components of drugs — has given it ...

Camzyos is an oral, selective allosteric and reversible inhibitor of cardiac myosin. It was approved in April 2022 for the treatment of adults with symptomatic New York Heart Association (NYHA) class ...